🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: To investigate the objective response rate in patients ...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2015-03
Trial ID
NCT02374489
Treatments Being Tested
This was a single-arm, open-label, multicenter, phase II study to evaluate ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-08-21
Trial ID
NCT02450903
Treatments Being Tested
ROS1 is a receptor tyrosine kinase with constitutive kinase activity. ROS1 ...
Status
Completed
Location
Yonsei Cancer Center at Yonsei University Medical Center
Start Date
2013-09-01
Trial ID
NCT01964157
Treatments Being Tested
The purpose of this study was to evaluate the anti-tumor activity of single...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-01-20
Trial ID
NCT02276027
The rollover study will provide ceritinib to patients who are currently rec...
Status
Active Not Recruiting
Location
Highlands Oncology Group
Start Date
2015-12-11
Trial ID
NCT02584933
Treatments Being Tested
The purpose of this study is to observe the clinical effect and safety of R...
Status
Unknown
Location
Multiple Locations
Start Date
2020-06
Trial ID
NCT04356118
This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studie...
Status
Terminated
Location
CTCA at Western Regional Medical Center
Start Date
2019-07-25
Trial ID
NCT03737994
Treatments Being Tested
The purpose of this research study is to match genomic aberrations in tumor...
Status
Terminated
Location
The Children's Hospital of Philadelphia
Start Date
2016-07
Trial ID
NCT02780128
This is an open label multi center trial to determine the safety and effica...
Status
Active Not Recruiting
Location
Mayo Clinic - Arizona
Start Date
2015-05-27
Trial ID
NCT02393625
Treatments Being Tested
A single-arm, open-label, two-stage multicenter, phase II study. Patients w...
Status
Completed
Location
Massachusetts General Hospital Mass Gen 5
Start Date
2012-12-20
Trial ID
NCT01685138
Treatments Being Tested